AAAAAA
Results:
1-16
|
Results: 16
Authors:
Molica, S
Citation: S. Molica, Angiogenesis in B-cell chronic lymphocytic leukemia: Methods of study, clinical significance and prognostic implications, LEUK LYMPH, 42(4), 2001, pp. 603-607
Authors:
Liso, V
Molica, S
Capalbo, S
Pogliani, E
Battista, C
Broccia, G
Montillo, M
Cuneo, A
Leoni, P
Specchia, G
Castoldi, G
Citation: V. Liso et al., Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy, HAEMATOLOG, 86(11), 2001, pp. 1165-1171
Authors:
Molica, S
Levato, D
Citation: S. Molica et D. Levato, What is changing in the natural history of chronic lymphocytic leukemia?, HAEMATOLOG, 86(1), 2001, pp. 8-12
Authors:
Molica, S
Vitelli, G
Levato, D
Giannarelli, D
Gandolfo, GM
Citation: S. Molica et al., Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression, CANCER, 92(4), 2001, pp. 713-719
Authors:
Gobbi, PG
Broglia, C
Berte, R
Petrilli, MP
Molica, S
Angrilli, F
Iannitto, E
Ghirardelli, ML
Di Renzo, N
Cavanna, L
Ascari, E
Citation: Pg. Gobbi et al., Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease, HAEMATOLOG, 85(7), 2000, pp. 722-728
Authors:
Molica, S
Santoro, R
Digiesi, G
Dattilo, A
Levato, D
Muleo, G
Citation: S. Molica et al., Vascular endothelial growth factor isoforms 121 and 165 are expressed on B-chronic lymphocytic leukemia cells, HAEMATOLOG, 85(10), 2000, pp. 1106-1108
Authors:
Molica, S
Citation: S. Molica, Is it time for a reassessment of prognostic features in B-cell chronic lymphocytic leukemia?, HEM CELL TH, 41(3), 1999, pp. 87-93
Authors:
Molica, S
Levato, D
Cascavilla, N
Levato, L
Musto, P
Citation: S. Molica et al., Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta(2)-microglobulin in B-cell chronic lymphocytic leukemia, EUR J HAEMA, 62(2), 1999, pp. 117-122
Authors:
Zinzani, PL
Magagnoli, M
Galieni, P
Martelli, M
Poletti, V
Zaja, F
Molica, S
Zaccaria, A
Cantonetti, AM
Gentilini, P
Guardigni, L
Gherlinzoni, F
Ribersani, M
Bendandi, M
Albertini, P
Tura, S
Citation: Pl. Zinzani et al., Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: Analysis of 75 patients, J CL ONCOL, 17(4), 1999, pp. 1254-1258
Authors:
Stelitano, C
Morabito, F
Kropp, MG
Callea, V
Iuliano, F
Oriana, V
Levato, D
Nobile, F
Molica, S
Brugiatelli, M
Citation: C. Stelitano et al., Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases, HAEMATOLOG, 84(4), 1999, pp. 317-323
Authors:
Molica, S
Vitelli, G
Levato, D
Levato, L
Dattilo, A
Gandolfo, GM
Citation: S. Molica et al., Clinico-biological implications of increased serum levels of interleukin-8in B-cell chronic lymphocytic leukemia, HAEMATOLOG, 84(3), 1999, pp. 208-211
Authors:
Molica, S
Levato, D
Dattilo, A
Citation: S. Molica et al., Natural history of early chronic lymphocytic leukemia. A single institution study with emphasis on the impact of disease progression on overall survival, HAEMATOLOG, 84(12), 1999, pp. 1094-1099
Authors:
Boccadoro, M
Tarella, C
Palumbo, A
Argentino, C
Triolo, S
Dominietto, A
Callea, V
Lauta, VM
Molica, S
Musto, P
Marmont, F
Gianni, AM
Pileri, A
Citation: M. Boccadoro et al., An analysis of which subgroups of multiple myeloma patients, divided according to beta(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy, HAEMATOLOG, 84(10), 1999, pp. 905-910
Authors:
Molica, S
Vitelli, G
Levato, D
Gandolfo, GM
Liso, V
Citation: S. Molica et al., Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia, BR J HAEM, 107(3), 1999, pp. 605-610
Authors:
Callea, V
Morabito, F
Oliva, BM
Stelitano, C
Levato, D
Dattilo, A
Gangemi, F
Iorfida, A
Iacopino, P
Nobile, F
Molica, S
Brugiatelli, M
Citation: V. Callea et al., Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is relatedto clinical outcome, BR J HAEM, 107(2), 1999, pp. 347-352
Authors:
Molica, S
Dattilo, A
Giulino, C
Levato, D
Levato, L
Citation: S. Molica et al., Increased bcl-2/bax ratio in B-cell chronic lymphocytic leukemia is associated with a progressive pattern of disease, HAEMATOLOG, 83(12), 1998, pp. 1122-1124
Risultati:
1-16
|